scholarly journals An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial

2018 ◽  
Vol 200 ◽  
pp. 17-23 ◽  
Author(s):  
Renato D. Lopes ◽  
Amit N. Vora ◽  
Danny Liaw ◽  
Christopher B. Granger ◽  
Harald Darius ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document